https://www.selleckchem.com/pr....oducts/BafilomycinA1
Overall baseline characteristics were similar between the two groups except for the incidence of bactremia/sepsis. After controlling for vancomycin area under the curve, baseline creatinine clearance, and intensive care unit admission in multivariable logistic regression, melatonin use was associated with a 63% decrease in AKI (odds ratio [OR], 0.37; 95% confidence interval [CI], 0.14 - 0.96; p =0.041). Conclusions Melatonin use was associated with a significant reduction in vancomycin-related AKI. Although this was a retrospectiv
Curtir
Comentario
Compartilhar
